ZA851281B - Pyrazolopyridine derivatives - Google Patents
Pyrazolopyridine derivativesInfo
- Publication number
- ZA851281B ZA851281B ZA851281A ZA851281A ZA851281B ZA 851281 B ZA851281 B ZA 851281B ZA 851281 A ZA851281 A ZA 851281A ZA 851281 A ZA851281 A ZA 851281A ZA 851281 B ZA851281 B ZA 851281B
- Authority
- ZA
- South Africa
- Prior art keywords
- pyrazolopyridine derivatives
- pyrazolopyridine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848404584A GB8404584D0 (en) | 1984-02-22 | 1984-02-22 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA851281B true ZA851281B (en) | 1985-11-27 |
Family
ID=10556988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA851281A ZA851281B (en) | 1984-02-22 | 1985-02-20 | Pyrazolopyridine derivatives |
Country Status (11)
Country | Link |
---|---|
US (1) | US4670432A (xx) |
EP (1) | EP0152910B1 (xx) |
JP (1) | JPS60193987A (xx) |
AU (1) | AU581207B2 (xx) |
CA (1) | CA1242714A (xx) |
DE (1) | DE3571437D1 (xx) |
ES (1) | ES8606341A1 (xx) |
GB (1) | GB8404584D0 (xx) |
GR (1) | GR850441B (xx) |
NZ (1) | NZ211166A (xx) |
ZA (1) | ZA851281B (xx) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT382377B (de) * | 1985-04-27 | 1987-02-25 | Beecham Group Plc | Verfahren zur herstellung von neuen 7-substituierten aminopyrazolo(4,3-b)pyridinen |
EP0239191A3 (en) * | 1986-01-30 | 1988-07-20 | Beecham Group Plc | Pyrazolo[4,3-b]pyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
GB8609421D0 (en) * | 1986-04-17 | 1986-05-21 | Beecham Group Plc | Compounds |
PE20020506A1 (es) * | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
EP1377573B1 (en) * | 2000-12-15 | 2005-07-27 | Glaxo Group Limited | Pyrazolopyridine derivatives |
US6919352B2 (en) | 2000-12-15 | 2005-07-19 | Smithkline Beecham Corporation | Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds |
AU2002248531A1 (en) * | 2001-03-08 | 2002-09-24 | Smithkline Beecham Corporation | Pyrazolopyriadine derivatives |
WO2002078701A1 (en) * | 2001-03-30 | 2002-10-10 | Smithkline Beecham Corporation | Use of pyrazolopyridines as therapeutic compounds |
WO2002078700A1 (en) | 2001-03-30 | 2002-10-10 | Smithkline Beecham Corporation | Pyralopyridines, process for their preparation and use as therapteutic compounds |
ATE332301T1 (de) * | 2001-04-10 | 2006-07-15 | Smithkline Beecham Corp | Antivirale pyrazolopyridin verbindungen |
WO2002088124A2 (en) * | 2001-04-27 | 2002-11-07 | Smithkline Beecham Corporation | Pyrazolo'1,5-a!pyridine derivatives |
CN1518550A (zh) * | 2001-06-21 | 2004-08-04 | ʷ��˿�������ȳ�ķ����˾ | 用于预防和治疗疱疹病毒感染的咪唑并[1,2-a]吡啶衍生物 |
EP1423389B1 (en) * | 2001-09-07 | 2007-06-06 | SmithKline Beecham Corporation | Pyrazolo-pyridines for the treatment of herpes infections |
EP1432712B1 (en) * | 2001-10-05 | 2006-05-17 | SmithKline Beecham Corporation | Imidazo-pyridine derivatives for use in the treatment of herpes viral infection |
ATE373000T1 (de) * | 2001-12-11 | 2007-09-15 | Smithkline Beecham Corp | Pyrazolopyridin-derivate als antiherpesmittel |
EP1546148A1 (en) * | 2002-10-03 | 2005-06-29 | SmithKline Beecham Corporation | Therapeutic compounds based on pyrazolopyridine derivatives |
US7459562B2 (en) | 2004-04-23 | 2008-12-02 | Bristol-Myers Squibb Company | Monocyclic heterocycles as kinase inhibitors |
TW200538453A (en) | 2004-04-26 | 2005-12-01 | Bristol Myers Squibb Co | Bicyclic heterocycles as kinase inhibitors |
US7432373B2 (en) | 2004-06-28 | 2008-10-07 | Bristol-Meyers Squibb Company | Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
US7173031B2 (en) | 2004-06-28 | 2007-02-06 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
US7439246B2 (en) | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
WO2007035428A1 (en) | 2005-09-15 | 2007-03-29 | Bristol-Myers Squibb Company | Met kinase inhibitors |
US7547782B2 (en) | 2005-09-30 | 2009-06-16 | Bristol-Myers Squibb Company | Met kinase inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4048184A (en) * | 1976-11-15 | 1977-09-13 | E. R. Squibb & Sons, Inc. | 6-Phenyl-2H-pyrazolo[3,4-b]pyridines |
DE3464368D1 (de) * | 1983-03-09 | 1987-07-30 | Beecham Group Plc | Anti-inflammatory pyrazolo pyridines |
EP0151962A3 (en) * | 1984-01-25 | 1985-10-02 | Beecham Group Plc | Pyrazolopyridine derivatives |
EP0193329A3 (en) * | 1985-02-22 | 1987-08-19 | Beecham Group Plc | Pyrazolopyridines, their preparation and pharmaceutical compositions containing them |
-
1984
- 1984-02-22 GB GB848404584A patent/GB8404584D0/en active Pending
-
1985
- 1985-02-13 EP EP85101566A patent/EP0152910B1/en not_active Expired
- 1985-02-13 DE DE8585101566T patent/DE3571437D1/de not_active Expired
- 1985-02-20 GR GR850441A patent/GR850441B/el unknown
- 1985-02-20 AU AU38972/85A patent/AU581207B2/en not_active Ceased
- 1985-02-20 ZA ZA851281A patent/ZA851281B/xx unknown
- 1985-02-20 CA CA000474776A patent/CA1242714A/en not_active Expired
- 1985-02-20 NZ NZ211166A patent/NZ211166A/en unknown
- 1985-02-21 JP JP60031699A patent/JPS60193987A/ja active Pending
- 1985-02-21 ES ES540609A patent/ES8606341A1/es not_active Expired
-
1986
- 1986-04-15 US US06/852,152 patent/US4670432A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE3571437D1 (de) | 1989-08-17 |
NZ211166A (en) | 1988-01-08 |
AU3897285A (en) | 1985-08-29 |
GB8404584D0 (en) | 1984-03-28 |
EP0152910B1 (en) | 1989-07-12 |
AU581207B2 (en) | 1989-02-16 |
ES540609A0 (es) | 1986-04-16 |
US4670432A (en) | 1987-06-02 |
EP0152910A3 (en) | 1986-07-16 |
GR850441B (xx) | 1985-06-19 |
EP0152910A2 (en) | 1985-08-28 |
CA1242714A (en) | 1988-10-04 |
JPS60193987A (ja) | 1985-10-02 |
ES8606341A1 (es) | 1986-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2163150B (en) | 3-aminopropoxyaryl derivatives | |
GB2152033B (en) | Sulfonamido-benzamide derivatives | |
EP0163324A3 (en) | Aminoalkylphenoxy derivatives | |
GB2155925B (en) | Pyrimidylpiperazine derivatives | |
ZA851281B (en) | Pyrazolopyridine derivatives | |
ZA851279B (en) | Pyrazolopyridine derivatives | |
GB2164644B (en) | Benzonorbornene derivatives | |
DE3565267D1 (en) | 9a-aza-9a-homoerythromycin derivatives | |
GB2159814B (en) | Iminothiazolidine derivatives | |
GB2165845B (en) | Dioxinopyridine derivatives | |
GB2162178B (en) | 4-cyano-3-oxo-hexahydro-isoquinoline derivatives | |
GB2165247B (en) | Azabicycloheptene derivatives | |
GB8419223D0 (en) | Sulphamoylguanidine derivatives | |
EP0174271A3 (en) | Anthraceme derivatives | |
GB2153818B (en) | Pyrazolopyridine derivatives | |
GB2158066B (en) | Apovincaminol derivatives | |
GB8422379D0 (en) | Derivatives | |
IE850147L (en) | Pyrazolopyridine derivatives | |
GB8429810D0 (en) | Indolizidine derivatives | |
IE843259L (en) | Pyrazolopyridine derivatives | |
GB2169290B (en) | Pyrone -3- carboxamide derivatives | |
GB8431989D0 (en) | Pyrazolopyridine derivatives | |
GB8401010D0 (en) | Thioketene derivatives | |
GB2165243B (en) | 17-sulphonamido yohimbane derivatives | |
IE850369L (en) | Naphthyridine derivatives |